Expression and function of PPARs in placenta

PPAR Research

Volumn , Issue , 2013, Pages

  Matsuda, Satoru ^a   Kobayashi, Mayumi ^a   Kitagishi, Yasuko ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; SIRTUIN; STAT5 PROTEIN;

GENE CONTROL; GENE EXPRESSION; PLACENTA; PLACENTA DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSACTIVATION;

EID: 84883824317     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2013/256508     Document Type: Review

References (69)

1. Vacca M., Degirolamo C., Mariani-Costantini R., Palasciano G., Moschetta A., Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2011 3 5 562 587 10.1002/wsbm.137
2. Schulman I. G., Nuclear receptors as drug targets for metabolic disease. Advanced Drug Delivery Reviews 2010 62 13 1307 1315 2-s2.0-78649325832 10.1016/j.addr.2010.07.002
3. Wahli W., Michalik L., PPARs at the crossroads of lipid signaling and inflammation. Trends in Endocrinology & Metabolism 2012 23 7 351 363 10.1016/j.tem.2012.05.001
4. Becker J., Delayre-Orthez C., Frossard N., Pons F., Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fundamental and Clinical Pharmacology 2006 20 5 429 447 2-s2.0-33748701308 10.1111/j.1472-8206.2006.00425.x
5. Giaginis C., Tsantili-Kakoulidou A., Theocharis S., Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Fundamental and Clinical Pharmacology 2007 21 3 231 244 2-s2.0-34249023565 10.1111/j.1472-8206.2007.00486.x
6. Nagy L., Szanto A., Szatmari I., Széles L., Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiological Reviews 2012 92 2 739 789 10.1152/physrev.00004.2011
7. Kruger M. C., Coetzee M., Haag M., Weiler H., Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone. Progress in Lipid Research 2010 49 4 438 449 2-s2.0-77956392414 10.1016/j.plipres.2010.06.002
8. Martínez N., Kurtz M., Capobianco E., Higa R., White V., Jawerbaum A., PPAR α agonists regulate lipid metabolism and nitric oxide production and prevent placental overgrowth in term placentas from diabetic rats. Journal of Molecular Endocrinology 2011 47 1 1 12 2-s2.0-79960999898 10.1530/JME-10-0173
9. Shalom-Barak T., Nicholas J. M., Wang Y., Zhang X., Ong E. S., Young T. H., Gendler S. J., Evans R. M., Barak Y., Peroxisome proliferator-activated receptor γ controls Muc1 transcription in trophoblasts. Molecular and Cellular Biology 2004 24 24 10661 10669 2-s2.0-10044235262 10.1128/MCB.24.24. 10661-10669.2004
10. Puttabyatappa M., VandeVoort C. A., Chaffin C. L., hCG-induced down-regulation of PPAR γ and liver X receptors promotes periovulatory progesterone synthesis by macaque granulosa cells. Endocrinology 2010 151 12 5865 5872 2-s2.0-78649844912 10.1210/en.2010-0698
11. Kowalewski M. P., Dyson M. T., Manna P. R., Stocco D. M., Involvement of peroxisome proliferator-activated receptor in gonadal steroidogenesis and steroidogenic acute regulatory protein expression. Reproduction, Fertility and Development 2009 21 7 909 922 2-s2.0-69249106487 10.1071/RD09027
12. Zhang H., Xu X., Chen L., Chen J., Hu L., Jiang H., Shen X., Molecular determinants of magnolol targeting both RXR α and PPAR γ PLoS One 2011 6 11, article e28253
13. Wendling O., Chambon P., Mark M., Retinoid X receptors are essential for early mouse development Land placentogenesis. Proceedings of the National Academy of Sciences of the United States of America 1999 96 2 547 551 2-s2.0-0033582236
14. Barak Y., Nelson M. C., Ong E. S., Jones Y. Z., Ruiz-Lozano P., Chien K. R., Koder A., Evans R. M., PPAR γ is required for placental, cardiac, and adipose tissue development. Molecular Cell 1999 4 4 585 595 2-s2.0-0033213637 10.1016/S1097-2765(00)80209-9
15. Schaiff W. T., Knapp F. F. Jr., Barak Y., Biron-Shental T., Nelson D. M., Sadovsky Y., Ligand-activated peroxisome proliferator activated receptor γ alters placental morphology and placental fatty acid uptake in mice. Endocrinology 2007 148 8 3625 3634 2-s2.0-34547121969 10.1210/en.2007-0211
16. Lambe K. G., Tugwood J. D., A human peroxisome-proliferator-activated receptor- γ is activated by inducers of adipogenesis, including thiazalidinedione drugs. European Journal of Biochemistry 1996 239 1 1 7 2-s2.0-0029977518
17. Schild R. L., Sonnenberg-Hirche C. M., Schaiff W. T., Bildirici I., Nelson D. M., Sadovsky Y., The kinase p38 regulates peroxisome proliferator activated receptor- γ in human trophoblasts. Placenta 2006 27 2-3 191 199 2-s2.0-28844447942 10.1016/j.placenta.2005.01.012
18. Degrelle S. A., Murthi P., Evain-Brion D., Fournier T., Hue I., Expression and localization of DLX3, PPARG and SP1 in bovine trophoblast during binucleated cell differentiation. Placenta 2011 32 11 917 920 10.1016/j.placenta.2011.08.014
19. Ruebner M., Langbein M., Strissel P. L., Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPAR γ /RXR α in placentogenesis. Journal of Cellular Biochemistry 2012 113 7 2383 2396 10.1002/jcb.24110
20. Ringseis R., Eder K., Influence of pharmacological PPAR α activators on carnitine homeostasis in proliferating and non-proliferating species. Pharmacological Research 2009 60 3 179 184 2-s2.0-67651108954 10.1016/j.phrs.2009.01.016
21. Wagner K. D., Wagner N., Peroxisome proliferator-activated receptor beta/delta (PPAR β / δ) acts as regulator of metabolism linked to multiple cellular functions. Pharmacology and Therapeutics 2010 125 3 423 435 2-s2.0-76749137586 10.1016/j.pharmthera.2009.12.001
22. Cipolletta D., Feuerer M., Li A., PPAR- γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012 486 7404 549 553
23. Huin C., Corriveau L., Bianchi A., Keller J. M., Collet P., Krémarik-Bouillaud P., Domenjoud L., Bécuwe P., Schohn H., Ménard D., Dauça M., Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract. Journal of Histochemistry and Cytochemistry 2000 48 5 603 611 2-s2.0-17544387857
24. Komar C. M., Curry T. E., Localization and expression of messenger RNAs for the peroxisome proliferator-activated receptors in ovarian tissue from naturally cycling and pseudopregnant rats. Biology of Reproduction 2002 66 5 1531 1539 2-s2.0-0036234471
25. Fedele L., Somigliana E., Frontino G., Benaglia L., Vigano P., New drugs in development for the treatment of endometriosis. Expert Opinion on Investigational Drugs 2008 17 8 1187 1202 2-s2.0-51449093045 10.1517/13543784.17.8.1187
26. Gui Y., Cai Z., Silha J. V., Murphy L. J., Variations in parametrial white adipose tissue mass during the mouse estrous cycle: relationship with the expression of peroxisome proliferator-activated receptor- γ and retinoic acid receptor- α Canadian Journal of Physiology and Pharmacology 2006 84 8-9 887 892 2-s2.0-33846360664 10.1139/Y06-032
27. Benz V., Kintscher U., Foryst-Ludwig A., Sex-specific differences in type 2 diabetes mellitus and dyslipidemia therapy: PPAR agonists. Handbook of Experimental Pharmacology 2012 214 387 410
28. Waku T., Shiraki T., Oyama T., Morikawa K., Atomic structure of mutant PPAR γ LBD complexed with 15d-PGJ2: novel modulation mechanism of PPAR γ /RXR α function by covalently bound ligands. FEBS Letters 2009 583 2 320 324 2-s2.0-58249099266 10.1016/j.febslet.2008.12.017
29. Yu S., Reddy J. K., Transcription coactivators for peroxisome proliferator-activated receptors. Biochimica et Biophysica Acta 2007 1771 8 936 951 2-s2.0-34547604561 10.1016/j.bbalip.2007.01.008
30. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M., 15-deoxy-Δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ Cell 1995 83 5 803 812 2-s2.0-0028972025
31. Yu Z., Schneider C., Boeglin W. E., Brash A. R., Epidermal lipoxygenase products of the hepoxilin pathway selectively activate the nuclear receptor PPAR α Lipids 2007 42 6 491 497 2-s2.0-34250795603 10.1007/s11745-007-3054-4
32. Ibabe A., Herrero A., Cajaraville M. P., Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR α-and PPAR γ -specific ligands and by 17 β -estradiol in isolated zebrafish hepatocytes. Toxicology in Vitro 2005 19 6 725 735 2-s2.0-20644450102 10.1016/j.tiv.2005.03. 019
33. Kouroumichakis I., Papanas N., Zarogoulidis P., Liakopoulos V., Maltezos E., Mikhailidis D. P., Fibrates: therapeutic potential for diabetic nephropathy? European Journal of Internal Medicine 2012 23 4 309 316 10.1016/j.ejim.2011.12. 007
34. Friedland S. N., Leong A., Filion K. B., The cardiovascular effects of peroxisome proliferator-activated receptor agonists. American Journal of Medicine 2012 125 2 126 133 10.1016/j.amjmed.2011.08.025
35. Saraf N., Sharma P. K., Mondal S. C., Garg V. K., Singh A. K., Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization. Journal of Pharmacy and Pharmacology 2012 64 2 161 171 10.1111/j.2042-7158.2011. 01366.x
36. Subbaramaiah K., Lin D. T., Hart J. C., Dannenberg A. J., Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. Journal of Biological Chemistry 2001 276 15 12440 12448 2-s2.0-0035853840 10.1074/jbc.M007237200
37. Matsumoto H., Ma W., Smalley W., Trzaskos J., Breyer R. M., Dey S. K., Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation. Biology of Reproduction 2001 64 5 1557 1565 2-s2.0-0035032139
38. Ruan K. H., Dogné J. M., Implications of the molecular basis of prostacyclin biosynthesis and signaling in pharmaceutical designs. Current Pharmaceutical Design 2006 12 8 925 941 10.2174/138161206776055994
39. Froment P., Gizard F., Defever D., Staels B., Dupont J., Monget P., Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. Journal of Endocrinology 2006 189 2 199 209 2-s2.0-33646810470 10.1677/joe.1.06667
40. Mendez M., LaPointe M. C., PPAR γ inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. Hypertension 2003 42 4 844 850 2-s2.0-0141928147 10.1161/01.HYP.0000085332. 69777.D1
41. Fournier T., Pavan L., Tarrade A., Schoonjans K., Auwerx J., Rochette-Egly C., Evain-Brion D., The role of PPAR- γ /RXR- α heterodimers in the regulation of human trophoblast invasion. Annals of the New York Academy of Sciences 2002 973 26 30 2-s2.0-0036959571
42. Tarrade A., Schoonjans K., Guibourdenche J., Bidart J. M., Vidaud M., Auwerx J., Rochette-Egly C., Evain-Brion D., PPAR γ /RXR α heterodimers are involved in human CG β synthesis and human trophoblast differentiation. Endocrinology 2001 142 10 4504 4514 2-s2.0-0034801962 10.1210/en.142.10.4504
43. Tarrade A., Rochette-Egly C., Guibourdenche J., Evain-Brion D., The expression of nuclear retinoid receptors in human implantation. Placenta 2000 21 7 703 710 2-s2.0-0033828141 10.1053/plac.2000.0568
44. Michalik L., Auwerx J., Berger J. P., Chatterjee V. K., Glass C. K., Gonzalez F. J., Grimaldi P. A., Kadowaki T., Lazar M. A., O'Rahilly S., Palmer C. N. A., Plutzky J., Reddy J. K., Spiegelman B. M., Staels B., Wahli W., International union of pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacological Reviews 2006 58 4 726 741 2-s2.0-33751533892 10.1124/pr.58.4.5
45. Wolf G., Is 9-cis-retinoic acid the endogenous ligand for the retinoic acid-X receptor? Nutrition Reviews 2006 64 12 532 538 2-s2.0-33846094038 10.1301/nr.2006.dec.532-538
46. Nezbedova P., Brtko J., 1 α25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action. Endocrine Regulations 2004 38 1 29 38 2-s2.0-4043083551
47. Clarke S. D., Thuillier P., Baillie R. A., Sha X., Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors. American Journal of Clinical Nutrition 1999 70 4 566 571 2-s2.0-0032867442
48. Wang Q., Fujii H., Knipp G. T., Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 2002 23 8-9 661 671 2-s2.0-0036730903 10.1053/plac.2002.0855
49. Handschuh K., Guibourdenche J., Cocquebert M., Tsatsaris V., Vidaud M., Evain-Brion D., Fournier T., Expression and regulation by PPAR γ of hCG α-and β -subunits: comparison between villous and invasive extravillous trophoblastic Cells. Placenta 2009 30 12 1016 1022 2-s2.0-70450224080 10.1016/j.placenta.2009.09.006
50. Holdsworth-Carson S. J., Permezel M., Rice G. E., Lappas M., Preterm and infection-driven preterm labor: the role of peroxisome proliferator-activated receptors and retinoid X receptor. Reproduction 2009 137 6 1007 1015 2-s2.0-68949206603 10.1530/REP-08-0496
51. Holdsworth-Carson S. J., Permezel M., Riley C., Rice G. E., Lappas M., Peroxisome Proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated Changes. Placenta 2009 30 2 176 186 2-s2.0-58249083984 10.1016/j.placenta.2008.11.013
52. Borel V., Gallot D., Marceau G., Sapin V., Blanchon L., Placental implications of peroxisome proliferator-activated receptors in gestation and parturition. PPAR Research 2008 2008 9 2-s2.0-38649116900 10.1155/2008/758562 758562
53. Lin S. J., Ford E., Haigis M., Liszt G., Guarente L., Calorie restriction extends yeast life span by lowering the level of NADH. Genes and Development 2004 18 1 12 16 2-s2.0-0347128279 10.1101/gad.1164804
54. Potente M., Ghaeni L., Baldessari D., Mostoslavsky R., Rossig L., Dequiedt F., Haendeler J., Mione M., Dejana E., Alt F. W., Zeiher A. M., Dimmeler S., SIRT1 controls endothelial angiogenic functions during vascular growth. Genes and Development 2007 21 20 2644 2658 2-s2.0-35348980724 10.1101/gad.435107
55. Oka S., Alcendor R., Zhai P., PPAR α -Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metabolism 2011 14 5 598 611 10.1016/j.cmet.2011.10.001
56. Legutko A., Marichal T., Fiévez L., Sirtuin 1 promotes Th2 responses and airway allergy by repressing peroxisome proliferator-activated receptor- γ activity in dendritic cells. The Journal of Immunology 2011 187 9 4517 4529 10.4049/jimmunol.1101493
57. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., De Oliveira R. M., Leid M., McBurney M. W., Guarente L., Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR- γ Nature 2004 429 6993 771 776 2-s2.0-3042681042 10.1038/nature02583
58. Miyashita H., Watanabe T., Hayashi H., Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1. PLoS One 2012 7 10, article e46459
59. Lappas M., Mitton A., Lim R., Barker G., Riley C., Permezel M., SIRT1 is a novel regulator of key pathways of human labor. Biology of Reproduction 2011 84 1 167 178 2-s2.0-78651511093 10.1095/biolreprod.110.086983
60. Kim J. K., Mun S., Kim M. S., Kim M. B., Sa B. K., Hwang J. K., 5, 7-Dimethoxyflavone, an activator of PPAR α / γ inhibits UVB-induced MMP expression in human skin fibroblast cells. Experimental Dermatology 2012 21 3 211 216 10.1111/j.1600-0625.2011.01435.x
61. Papageorgiou E., Pitulis N., Msaouel P., Lembessis P., Koutsilieris M., The non-genomic crosstalk between PPAR- γ ligands and ERK1/2 in cancer cell lines. Expert Opinion on Therapeutic Targets 2007 11 8 1071 1085 2-s2.0-34547792266 10.1517/14728222.11.8.1071
62. Pang T., Wang J., Benicky J., Sánchez-Lemus E., Saavedra J. M., Telmisartan directly ameliorates the neuronal inflammatory response to IL-1 β partly through the JNK/c-Jun and NADPH oxidase pathways. Journal of Neuroinflammation 2012 9 1 102 10.1186/1742-2094-9-102
63. Patel N., Gonsalves C. S., Malik P., Kalra V. K., Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 α Blood 2008 112 3 856 865 2-s2.0-50949112902 10.1182/blood-2007-12-130567
64. Maldonado-Pérez D., Brown P., Morgan K., Millar R. P., Thompson E. A., Jabbour H. N., Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway. Biochimica et Biophysica Acta 2009 1793 7 1315 1324 2-s2.0-67649390793 10.1016/j.bbamcr.2009.03.008
65. Zhang W., Zhang Y., Zhang H., Wang J., Cui R., Dai J., Sex differences in transcriptional expression of FABPs in zebrafish liver after chronic perfluorononanoic acid exposure. Environmental Science & Technology 2012 46 9 5175 5182 10.1021/es300147w
66. Keller J. M., Collet P., Bianchi A., Huin C., Bouillaud-Kremarik P., Becuwe P., Schohn H., Domenjoud L., Dauca M., Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease. International Journal of Developmental Biology 2000 44 5 429 442 2-s2.0-0033774715
67. Campbell S. E., Mehan K. A., Tunstall R. J., Febbraio M. A., Cameron-Smith D., 17 β -Estradiol upregulates the expression of peroxisome proliferator-activated receptor α and lipid oxidative genes in skeletal muscle. Journal of Molecular Endocrinology 2003 31 1 37 45 2-s2.0-0041852780 10.1677/jme.0.0310037
68. White U. A., Stephens J. M., Transcriptional factors that promote formation of white adipose tissue. Molecular and Cellular Endocrinology 2010 318 1-2 10 14 10.1016/j.mce.2009.08.023
69. Jung H. S., Lee Y. J., Kim Y. H., Paik S., Kim J. W., Lee J. W., Peroxisome proliferator-activated receptor gamma/signal transducers and activators of transcription 5A pathway plays a key factor in adipogenesis of human bone marrow-derived stromal cells and 3T3-L1 preadipocytes. Stem Cells and Development 2012 21 3 465 475 10.1089/scd.2010.0591